1114
P. Zhao et al. / Spectrochimica Acta Part A 75 (2010) 1108–1114
binding affinity and the 1O2 productivity are key factors for the DNA
photocleavage of porphyrins.
[5] G.A. Cisneros, L. Perera, R.M. Schaaper, L.C. Pedersen, R.E. London, L.G. Pedersen,
T.A. Darden, J. Am. Chem. Soc. 131 (2009) 1550–1556.
[6] L.N. Ji, X.H. Zou, J.G. Liu, Coord. Chem. Rev. 216–217 (2001) 513–536.
[7] F.R. Keene, J.A. Smith, J.G. Collins, Coord. Chem. Rev. 253 (2009) 2021–2035.
[8] A.M. Pizarro, P.J. Sadler, Biochimie 91 (2009) 1198–1211.
[9] E. Fouquet, J. Bernadou, B.J. Meunier, G. Pratviel, Chem. Commun. 15 (1987)
1169–1171.
4. Conclusions
Based on absorption, fluorescence, SERS, ICD spectroscopy, ther-
mal denaturation and viscosity measurements, the binding modes
of Cu(II)−, Zn(II), Co(III), Mn(III) tricationic metalloporphyrins to CT
DNA were investigated in comparison with the free base porphyrin,
which is a good DNA intercalator. The intrinsic DNA-binding con-
stants of these tricationic metalloporphyrins are lower than that
of free base porphyrin 1, suggesting that the insertion of metal
ions greatly influences the binding of cationic porphyrins to DNA.
Among the four metalloporphyrins, only porphyrin 3 intercalates
into DNA, while the other three complexes, Zn(II)−, Co(III), Mn(III)
porphyrins bind to DNA in non-intercalative mode (outside or
groove). This somewhat surprising result may be best understood
by the steric hindrance effect that Cu(II) has no axial ligands when
coordinating with porphyrin plane while Zn(II)−, Co(III), Mn(III)
all have H2O or Cl on axial position of porphyrin plane. Although
have lower Kb, the metalloporphyrin have comparative DNA photo-
cleavage with the free base porphyrin. This could be explained by
the higher 1O2 productivities of the metal complexes which also
result from the steric hindrance. These results are helpful in bet-
ter understanding the DNA interactions of cationic porphyrins and
may facilitate the design of new anticancer drugs.
[10] D.K. Deda, A.F. Uchoa, E. Caritá, M.S. Baptista, H.E. Toma, K. Araki, Int. J. Pharm.
376 (2009) 76–83.
[11] B. Ward, A. Skorobogarty, J.C. Dabrowiak, Biochemistry 25 (1986) 6875–6883.
[12] M. Tabata, K. Nakajima, E. Nyarko, J. Inorg. Biochem. 78 (2000) 383–389.
[13] L. Guo, W.J. Dong, X.F. Tong, C. Dong, S.M. Shuang, Talanta 70 (2006) 630–636.
[14] R.F. Pasternack, P. Garrity, B. Ehrlich, C.B. Davis, E.J. Gibbs, G. Orloff, A. Giartosio,
C. Turano, Nucleic Acids Res. 14 (1986) 5919–5931.
[15] R.F. Pasternack, E.J. Gibbs, J.J. Villafranca, Biochemistry 22 (1983) 2406–2414.
[16] L.A. Lipscomb, F.X. Zhou, S.R. Presnell, R.J. Woo, M.E. Peek, R.R. Plaskon, L.D.
Williams, Biochemistry 35 (1996) 2818–2823.
[17] M. Tabata, A.K. Sarker, E. Nyarko, J. Inorg. Biochem. 94 (2003) 50–58.
[18] R.K. Wall, A.H. Shelton, L.C. Bonaccorsi, S.A. Bejune, D.R. McMillin, J. Am. Chem.
Soc. 123 (2001) 11480–11481.
[19] P. Zhao, L.C. Xu, J.W. Huang, K.C. Zheng, B. Fu, H.C. Yu, L.N. Ji, Biophys. Chem.
135 (2008) 102–109.
[20] P. Zhao, L.C. Xu, J.W. Huang, K.C. Zheng, B. Fu, H.C. Yu, L.N. Ji, Spectrochim. Acta
A 71 (2008) 1216–1223.
[21] P. Zhao, L.C. Xu, J.W. Huang, K.C. Zheng, B. Fu, H.C. Yu, L.N. Ji, Biophys. Chem.
134 (2008) 72–83.
[22] P. Zhao, L.C. Xu, J.W. Huang, K.C. Zheng, B. Fu, H.C. Yu, L.N. Ji, Bioorg. Chem. 36
(2008) 278–287.
[23] C. Casas, B. Saint-Jalmes, C. Loup, C.J. Lacey, B. Meunier, J. Org. Chem. 58 (1993)
2913–2917.
[24] M.E. Reichmann, S.A. Rice, C.A. Thomas, P. Doty, J. Am. Chem. Soc. 76 (1954)
3047–3053.
[25] N.T. Sergei, A.G. Victor, S.C. Vladimir, T. Pierre-Yves, J. Raman Spectrosc. 36
(2005) 962–973.
[26] B.C. Baguley, M. Lebret, Biochemistry 23 (1984) 937–943.
[27] J.R. Lakowicz, G. Webber, Biochemistry 12 (1973) 4161–4170.
[28] J.B. Lepecp, C. Paoletti, J. Mol. Biol. 27 (1967) 87–106.
[29] J.D. Groot, R.E. Hester, J. Phys. Chem. 91 (1987) 1693–1696.
[30] C.Y. Wei, G.Q. Jia, J.L. Yuan, Z.C. Feng, C. Li, Biochemistry 45 (2006) 6681–6691.
[31] M. Procházka, P.Y. Turpin, J. Sy¨teˇpánek, J. Bok, J. Mol. Struct. 482–483 (1999)
221–224.
Acknowledgements
This work was financially supported by the three following units
of the People’s Republic of China: the National Natural Science
Foundation (29971034, 20071034, 20231010), the N.S.F. of Guang-
dong Province and Guangzhou Municipality Science &Technology
Bureau.
[32] S.N. Terekhov, S.G. Kruglik, V.L. Malinovskii, V.A. Galievsky, V.S. Chirvony, P.Y.
Turpin, J. Raman Spectrosc. 34 (2003) 868–881.
[33] E. Gaudry, J. Aubard, H. Amouri, G. Levi1, C. Cordier, Biopolymers 82 (2006)
399–404.
[34] J. Hanzlıková, M. Procházka, J. Sy¨teˇpánek, J. Bok, V. Baumruk, P.J. Anzenbacher,
J. Raman Spectrosc. 29 (1998) 575–584.
[35] H.T. Daryono, M. Shunsuke, A. Takehiro, Y. Naoki, I. Hidenari, J. Inorg. Biochem.
85 (2001) 219–228.
[36] S. Satyanarayana, J.C. Dabrowiak, J.B. Chaires, Biochemistry 32 (1993)
2573–2584.
[37] J.K. Barton, A.L. Raphael, J. Am. Chem. Soc. 106 (1984) 2466–2468.
[38] T.J. Dougherty, C.J. Gomer, B.W. Henderson, G. Jori, D. Kessel, M. Korbelik, J.
Moan, Q. Peng, J. Natl. Cancer Inst. 90 (1998) 889–905.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
References
[39] E.D. Sternberg, D. Dolphin, C. Bruckner, Tetrahedron 54 (1998) 4151–4202.
[40] T. Jia, Z.X. Jiang, K. Wang, Z.Y. Li, Biophys. Chem. 119 (2006) 295–302.
[41] Y. Ishikawa, N. Yamakawa, T. Uno, Bioorg. Med. Chem. 10 (2002) 1953–1960.
[42] N. Yamakawa, Y. Ishikawa, T. Uno, Chem. Pharm. Bull. 49 (2001) 1531–1540.
[43] H. Taima, A. Okubo, N. Yoshioka, H. Inoue, Chem. Eur. J. 12 (2006) 6331–6340.
[44] B. Chen, W. Qin, P. Wang, T. Tian, H.J. Ma, X.P. Cao, X.J. Wu, X. Zhou, X.L. Zhang,
F. Liu, F. Zheng, X. Li, Bioorg. Med. Chem. Lett. 13 (2003) 3731–3733.
[1] M. Kalek, A.S. Madsen, J. Wengel, J. Am. Chem. Soc. 129 (2007) 9392–9400.
[2] A. Bagno, G. Saielli, J. Am. Chem. Soc. 129 (2007) 11360–11361.
[3] D. Böhme, N. Düpre, D.A. Megger, J. Müller, Inorg. Chem. 46 (2007)
10114–10119.
[4] E. Almaraz, Q.A. Paula, Q. Liu, J.H. Reibenspies, M.Y. Darensbourg, N.P. Farrell, J.
Am. Chem. Soc. 130 (2008) 6272–6280.